Indaptus Therapeutics Inc (INDP) - Total Liabilities

Latest as of September 2025: $2.23 Million USD

Based on the latest financial reports, Indaptus Therapeutics Inc (INDP) has total liabilities worth $2.23 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Indaptus Therapeutics Inc (INDP) cash conversion ratio to assess how effectively this company generates cash.

Indaptus Therapeutics Inc - Total Liabilities Trend (2008–2024)

This chart illustrates how Indaptus Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Check Indaptus Therapeutics Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.

Indaptus Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Indaptus Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Cre8 Enterprise Limited Class A Ordinary Shares NASDAQ:CRE	USA	$47.14 Million
Codrus Minerals Ltd AU:CDR	Australia	AU$543.91K
Euroespes S.A. MC:EEP	Spain	€5.22 Million
International Lithium Corp V:ILC	Canada	CA$306.66K
Inix Technologies Holdings Bhd KLSE:0094	Malaysia	RM23.75 Million
Jet.AI Inc. NASDAQ:JTAI	USA	$3.71 Million
Sherpa II Holdings Corp V:SHRP	Canada	CA$42.88K

Liability Composition Analysis (2008–2024)

This chart breaks down Indaptus Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INDP market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Indaptus Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Indaptus Therapeutics Inc (2008–2024)

The table below shows the annual total liabilities of Indaptus Therapeutics Inc from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	$3.39 Million	+19.19%
2023-12-31	$2.85 Million	-17.07%
2022-12-31	$3.43 Million	-26.59%
2021-12-31	$4.68 Million	+132.05%
2020-12-31	$2.02 Million	-79.32%
2019-12-31	$9.74 Million	+22.35%
2018-12-31	$7.96 Million	+38.59%
2017-12-31	$5.75 Million	+184.93%
2016-12-31	$2.02 Million	+22.59%
2015-12-31	$1.65 Million	-45.50%
2014-12-31	$3.02 Million	-31.16%
2013-12-31	$4.39 Million	+377.57%
2012-12-31	$918.23K	-28.80%
2011-12-31	$1.29 Million	+25.12%
2010-12-31	$1.03 Million	-40.06%
2009-12-31	$1.72 Million	-59.63%
2008-12-31	$4.26 Million	--

About Indaptus Therapeutics Inc

NASDAQ:INDP USA Biotechnology

Market Cap

$4.80 Million

Market Cap Rank

#28794 Global

#5657 in USA

Share Price

$2.14

Change (1 day)

-23.57%

52-Week Range

$0.27 - $12.87

All Time High

$8680.00